Institut Universitaire De Cardiologie Et De Pneumologie De Québec, University Laval
Clinical trials sponsored by Institut Universitaire De Cardiologie Et De Pneumologie De Québec, University Laval, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New heart valve aims for better Long-Term results Results expected Oct 2026 (estimated)
- New disposable freezing catheter could make lung biopsies simpler Results expected Mar 2027 (estimated)
- Blood test may spot hidden heart killer Results expected Jul 2027 (estimated)
- Which sedation works best for lung biopsy? new trial aims to find out Results expected Aug 2027 (estimated)
- Heart valve showdown: which measurement method wins for TAVR patients? Results expected Sep 2027 (estimated)
-
New study uses wearable ECG to catch hidden heart problems after TAVI
Knowledge-focused OngoingThis study follows 200 people who had a heart valve replacement (TAVI) to see how often they experience heart rhythm problems in the weeks after the procedure. Participants wear a portable ECG monitor for up to 4 weeks after leaving the hospital. The goal is to learn how common t…
Sponsor: Institut universitaire de cardiologie et de pneumologie de Québec, University Laval • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Lung cancer biopsy study: fewer needle passes may be enough for genetic tests
Knowledge-focused OngoingThis study looks at the best way to collect tissue samples from lung cancer patients using a thin tube passed through the mouth (endobronchial ultrasound). It compares taking 2 versus 3 samples from each lymph node to see if fewer samples still provide enough material for genetic…
Sponsor: Institut universitaire de cardiologie et de pneumologie de Québec, University Laval • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:14 UTC